Cascade of Costs Could Push Gene Therapy Over $1 Million Per Patient – Managed Care magazine
Medscape |
Cascade of Costs Could Push Gene Therapy Over $1 Million Per Patient
Managed Care magazine Outrage over the cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the first U.S. gene therapy, tisagenlecleucel (Kymriah, Novartis), a leukemia treatment approved in August. But total costs for … Patients could end up paying more than $1M for new gene therapy |
